Comparison between On-Line High-Efficiency Hemodiafiltration and Conventional High-Flux Hemodialysis for Polyclonal Free Light Chain Removal

被引:11
作者
Lamy, Thomas [1 ]
Henri, Patrick [1 ]
Lobbedez, Thierry [1 ]
Comby, Elisabeth [2 ]
Ryckelynck, Jean-Philippe [1 ]
Ficheux, Maxence [1 ]
机构
[1] CHU Clemenceau, Dept Nephrol, FR-14033 Caen, France
[2] CHU Clemenceau, Dept Immunol, FR-14033 Caen, France
关键词
Hemodialysis; Hemodiafiltration; Polyclonal free light chains; SERUM; DIALYSIS; HEMOFILTRATION; MORTALITY; BETA-2-MICROGLOBULIN; CLEARANCE; RISK;
D O I
10.1159/000357968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Polyclonal free light chains (FLC) are considered as middle molecular weight uremic toxins in chronic kidney disease. In this study, we investigate polyclonal FLC removal by comparing conventional high-flux hemodialysis (HD) and online high-efficiency hemodiafiltration (ol-HDF) in end-stage renal disease patients. Methods: We analyzed 31 chronic dialysis patients who were treated by HD then by postdilution ol-HDF during a prospective study. All patients were anuric and without monoclonal gammopathy. Serum pre- and postdialysis FLC were collected during 4 sessions: 1 HD session and 3 ol-HDF sessions. We calculated the reduction ratio using kinetic modeling. Results: The kappa reduction ratio was higher with ol-HDF than with HD (66 +/- 14 vs. 52 +/- 13%, p < 0.001). However, the lambda reduction ratio was not significantly higher with ol-HDF (37 +/- 20 vs. 37 +/- 15%, p = 0.67). Furthermore, predialysis kappa- and lambda-FLC increased with ol-HDF compared with HD (kappa 155 +/- 82 vs. 87 +/- 47 mg/l, p < 0.05; lambda 101 +/- 46 vs. 72 +/- 41 mg/l, p < 0.05). Postdialysis FLC levels were raised only for lambda-FLC with ol-HDF (74 +/- 39 vs. 53 +/- 31 mg/l, p < 0.05) and were not significantly different for kappa. Conclusions: This study shows that lambda-FLC removal is better in ol-HDF compared with HD, whereas there is no difference in kappa-FLC removal. Surprisingly, predialysis kappa and lambda levels are both increased in ol-HDF, which is disturbing since polyclonal excess of lambda-FLC is associated with mortality in chronic kidney disease. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:93 / 98
页数:6
相关论文
共 32 条
  • [1] Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study
    Anandram, Seetharam
    Assi, Lakhvir Kaur
    Lovatt, Tracy
    Parkes, Jayne
    Taylor, Joanne
    Macwhannell, Alan
    Jacob, Abraham
    Handa, Sunil
    Harding, Stephen
    Basu, Supratik
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (11) : 1036 - 1042
  • [2] Myeloma light chains are ligands for cubilin (gp280)
    Batuman, V
    Verroust, PJ
    Navar, GL
    Kaysen, JH
    Goda, FO
    Campbell, WC
    Simon, E
    Pontillon, F
    Lyles, M
    Bruno, J
    Hammond, TG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (02) : F246 - F254
  • [3] BERGSTROM J, 1987, LANCET, V1, P628
  • [4] On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells:: A prospective, crossover study
    Carracedo, Julia
    Merino, Ana
    Nogueras, Sonia
    Carretero, Diana
    Berdud, Isabel
    Ramirez, Rafael
    Tetta, Ciro
    Rodriguez, Mariano
    Martin-Malo, Alejandro
    Aljama, Pedro
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08): : 2315 - 2321
  • [5] Cohen G, 1995, J AM SOC NEPHROL, V6, P1592
  • [6] Immunoglobulin light chains in uremia
    Cohen, G
    [J]. KIDNEY INTERNATIONAL, 2003, 63 : S15 - S18
  • [7] Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients
    Cohen, G
    Rudnicki, M
    Schmaldienst, S
    Hörl, WH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 879 - 883
  • [8] Free Immunoglobulin Light Chains as a Risk Factor in Renal and Extrarenal Complications
    Cohen, Gerald
    Hoerl, Walter H.
    [J]. SEMINARS IN DIALYSIS, 2009, 22 (04) : 369 - 372
  • [9] Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population
    Dispenzieri, Angela
    Katzmann, Jerry A.
    Kyle, Robert A.
    Larson, Dirk R.
    Therneau, Terry M.
    Colby, Colin L.
    Clark, Raynell J.
    Mead, Graham P.
    Kumar, Shaji
    Melton, L. Joseph, III
    Rajkumar, S. Vincent
    [J]. MAYO CLINIC PROCEEDINGS, 2012, 87 (06) : 517 - 523
  • [10] Randomized Controlled Pilot Study of 2 Weeks' Treatment With High Cutoff Membrane for Hemodialysis Patients With Elevated C-Reactive Protein
    Fiedler, Roman
    Neugebauer, Felix
    Ulrich, Christof
    Wienke, Andreas
    Gromann, Cora
    Storr, Markus
    Boehler, Torsten
    Seibert, Eric
    Girndt, Matthias
    [J]. ARTIFICIAL ORGANS, 2012, 36 (10) : 886 - 893